Dr. Sven STEGEMANN Professor of Patient Centric Drug Design and Manufacturing, Graz University of Technology, and Research Center Pharmaceutical Engineering GmbH; Director, Pharmaceutical Business Development, Capsugel S.A., Colmar
CV
| 1992-1996 | Scientific Manager, Project-coordination, Sanofi-Winthrop, Munich |
| 1995-1996 | Vice Manufacturing Manager; Head of Galenical Development, Plantorgan (Sanofi-Winthrop), Bad Zwischenahn |
| Project Manager Manufacturing Transfer, Sanofi Winthrop, Munich | |
| 1996-1997 | Manager Licensing, Asta Medica, Frankfurt |
| 1997-2004 | Business Development Manager, Capsugel, Bornem |
| since 2014 | Director Pharmaceutical Development, Capsugel, Bornem |
| Professor, Patient centric Drug Product Development and Manufacturing, Graz University of Technology, Graz |
Mitgliedschaften
| AAPS, APV, EUFEPS, GSA |
Publikationen
| Stegemann S, Ternik RL, Onder G, Khan MA, van Riet-Nales DA: Defining patient centric pharmaceutical drug product design, 2016 | |
| Stegemann S, Connolly P, Matthew W, Barnett R, Schrooten K, Cade D., Taylor A: Application of QbD principles for the evaluation of capsules in formulation development and manufacturing, 2014 | |
| Stegemann S, Gosch M, Breitkreutz J., Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy, 2012 | |
| Stegemann S, Ecker F, Maio M, Kraahs P, Wohlfahrt R, Breitkreutz J, Zimmer A, Bar-Shalom D, Hettrich P, Broegmann B: Geriatric drug therapy: neglecting the inevitable majority, 2010 |
Auszeichnungen
| Recipient of the 2015 Outstanding Manuscript Award in AAPS PharmSciTech | |
| Recipient of the MSE Service Award 2015 | |
| Elected as an AAPS Fellow |
